Jonathan P. Bestwick

7.9k total citations · 5 hit papers
113 papers, 5.0k citations indexed

About

Jonathan P. Bestwick is a scholar working on Pediatrics, Perinatology and Child Health, Neurology and Infectious Diseases. According to data from OpenAlex, Jonathan P. Bestwick has authored 113 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pediatrics, Perinatology and Child Health, 27 papers in Neurology and 22 papers in Infectious Diseases. Recurrent topics in Jonathan P. Bestwick's work include Prenatal Screening and Diagnostics (30 papers), Parkinson's Disease Mechanisms and Treatments (22 papers) and Parvovirus B19 Infection Studies (21 papers). Jonathan P. Bestwick is often cited by papers focused on Prenatal Screening and Diagnostics (30 papers), Parkinson's Disease Mechanisms and Treatments (22 papers) and Parvovirus B19 Infection Studies (21 papers). Jonathan P. Bestwick collaborates with scholars based in United Kingdom, United States and Italy. Jonathan P. Bestwick's co-authors include David S Wald, Nicholas Wald, Hafiz Naderi, Alastair J. Noyce, Joan K. Morris, Andrew J. Lees, Gavin Giovannoni, Anette Schrag, Matthew Law and Christopher H. Hawkes and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Jonathan P. Bestwick

104 papers receiving 4.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adherence to Drugs That Prevent Cardiovascular Disease: Meta-analysis on 376,162 Patients

2012 584 citations Jonathan P. Bestwick, David S Wald et al. The American Journal of Medicine profile →
Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials

2009 567 citations David S Wald, Matthew Law et al. The American Journal of Medicine profile →
Meta‐analysis of early nonmotor features and risk factors for Parkinson disease

2012 515 citations Alastair J. Noyce, Jonathan P. Bestwick et al. Annals of Neurology profile →
Antenatal Thyroid Screening and Childhood Cognitive Function

2012 420 citations Jonathan P. Bestwick, Lynne M. George et al. profile →
Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases

2013 366 citations Ruth Dobson, Jonathan P. Bestwick et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan P. Bestwick United Kingdom	31	1.3k	1.1k	1.0k	817	592	113	5.0k
David Gaist Denmark	42	1.0k 0.8×	285 0.3×	919 0.9×	884 1.1×	451 0.8×	149	5.6k
Abraham A. Kroon Netherlands	49	613 0.5×	1.4k 1.3×	4.6k 4.6×	1.8k 2.2×	311 0.5×	269	9.1k
Birgitta Stegmayr Sweden	51	834 0.6×	697 0.7×	2.2k 2.2×	540 0.7×	207 0.3×	108	8.1k
Heidi Taipale Finland	38	260 0.2×	282 0.3×	415 0.4×	251 0.3×	342 0.6×	257	5.8k
Bo Carlberg Sweden	32	565 0.4×	987 0.9×	2.4k 2.4×	528 0.6×	106 0.2×	88	4.8k
Donald G. Grosset United Kingdom	46	4.1k 3.1×	197 0.2×	623 0.6×	282 0.3×	192 0.3×	168	6.4k
Nanne Kleefstra Netherlands	34	213 0.2×	1.6k 1.5×	718 0.7×	633 0.8×	142 0.2×	166	4.3k
Amytis Towfighi United States	30	1.1k 0.8×	631 0.6×	2.6k 2.5×	673 0.8×	283 0.5×	89	7.5k
Enrico Cagliero United States	41	203 0.2×	3.1k 2.9×	689 0.7×	818 1.0×	173 0.3×	82	6.2k
Olivier Hanon France	42	211 0.2×	491 0.5×	3.3k 3.3×	666 0.8×	119 0.2×	298	6.1k

Countries citing papers authored by Jonathan P. Bestwick

Since Specialization

Citations

This map shows the geographic impact of Jonathan P. Bestwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan P. Bestwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan P. Bestwick more than expected).

Fields of papers citing papers by Jonathan P. Bestwick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan P. Bestwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan P. Bestwick. The network helps show where Jonathan P. Bestwick may publish in the future.

Co-authorship network of co-authors of Jonathan P. Bestwick

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan P. Bestwick. A scholar is included among the top collaborators of Jonathan P. Bestwick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan P. Bestwick. Jonathan P. Bestwick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jacobs, Benjamin M., et al.. (2025). Pre‐Diagnostic Features of Multiple Sclerosis in a Diverse UK Cohort: A Nested Case–Control Study. Annals of Clinical and Translational Neurology. 13(1). 71–84. 1 indexed citations

Wald, Nicholas, et al.. (2025). Blood folate level needed for fully effective fortification in the prevention of neural tube defects. Archives of Disease in Childhood. 110(8). 651–656. 1 indexed citations

Bestwick, Jonathan P., Mark Jitlal, Sarah Morgan‐Trimmer, et al.. (2025). Early presentations of dementia in a diverse population. Alzheimer s & Dementia. 21(2). e14578–e14578. 2 indexed citations

Bestwick, Jonathan P., Sarah Morgan‐Trimmer, Claudia Cooper, et al.. (2024). Pre‐diagnostic manifestations of Alzheimer’s disease: A systematic review and meta‐analysis of longitudinal studies. Alzheimer s & Dementia. 20(S3). e085949–e085949. 1 indexed citations

Ammoscato, Francesca, Jonathan P. Bestwick, Michael Andrews, et al.. (2024). Cladribine tablets in relapsing-remitting multiple sclerosis preferentially target B-cells. Clinical Immunology. 269. 110380–110380. 4 indexed citations

Tallantyre, Emma, Patricia A. Kelly, Maria Isabel Leite, et al.. (2024). Impact of rituximab treatment regime on time to relapse in aquaporin-4 antibody positive neuromyelitis optica spectrum disorder. Multiple Sclerosis and Related Disorders. 85. 105528–105528.

Jacobs, Benjamin M., Jonathan P. Bestwick, Alastair J. Noyce, et al.. (2023). Modifiable risk factors for multiple sclerosis have consistent directions of effect across diverse ethnic backgrounds: a nested case–control study in an English population-based cohort. Journal of Neurology. 271(1). 241–253. 6 indexed citations

Dobson, Ruth, David W. Holden, Nicola Vickaryous, et al.. (2023). A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosis. Multiple Sclerosis Journal. 30(1). 63–70. 1 indexed citations

Simonet, Cristina, Philipp Mahlknecht, Kathrin Marini, et al.. (2023). The Emergence and Progression of Motor Dysfunction in Individuals at Risk of Parkinson's Disease. Movement Disorders. 38(9). 1636–1644. 7 indexed citations

10.

Senkevich, Konstantin, Jonathan P. Bestwick, Benjamin M. Jacobs, et al.. (2021). Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression. Movement Disorders. 36(6). 1420–1429. 135 indexed citations

11.

Bestwick, Jonathan P., William Gelson, Kosh Agarwal, et al.. (2020). English hepatitis C registry data show high response rates to directly acting anti‐virals, even if treatment is not completed. Alimentary Pharmacology & Therapeutics. 52(1). 168–181. 8 indexed citations

12.

Jacobs, Benjamin M., Jonathan P. Bestwick, Cornelis Blauwendraat, et al.. (2020). Parkinson’s disease determinants, prediction and gene–environment interactions in the UK Biobank. Journal of Neurology Neurosurgery & Psychiatry. 91(10). 1046–1054. 74 indexed citations

13.

Abdel‐Gadir, Amna, et al.. (2019). TCT-789 Comparison of Radial With Femoral Access Coronary Angiography in Patients With Previous Coronary Artery Bypass Surgery. Journal of the American College of Cardiology. 74(13). B773–B773. 2 indexed citations

14.

Morris, Joan K., et al.. (2018). Evaluation of stability of directly standardized rates for sparse data using simulation methods. Population Health Metrics. 16(1). 19–19. 12 indexed citations

15.

Noyce, Alastair J., et al.. (2016). Subtle motor disturbances in PREDICT-PD participants. Journal of Neurology Neurosurgery & Psychiatry. 88(3). 212–217. 17 indexed citations

16.

Wald, David A., et al.. (2013). Abstract MP38: INTERACT Investigation of Text Message Reminders on Adherence to Cardiac Treatment - Pilot Study. Circulation. 127. 1 indexed citations

17.

Wald, Nicholas, Jonathan P. Bestwick, Lynne M. George, & Wayne J. Huttly. (2012). Antenatal Screening for Down Syndrome Using Serum Placental Growth Factor with the Combined, Quadruple, Serum Integrated and Integrated Tests. PLoS ONE. 7(10). e46955–e46955. 12 indexed citations

18.

Noyce, Alastair J., Jonathan P. Bestwick, Laura Silveira‐Moriyama, et al.. (2012). Meta‐analysis of early nonmotor features and risk factors for Parkinson disease. Annals of Neurology. 72(6). 893–901. 515 indexed citations breakdown →

19.

Wald, David S, Matthew Law, Joan K. Morris, Jonathan P. Bestwick, & Nicholas Wald. (2009). Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials. The American Journal of Medicine. 122(3). 290–300. 567 indexed citations breakdown →

20.

Wald, David S, et al.. (2008). A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a β-blocker on blood pressure reduction. Clinical Therapeutics. 30(11). 2030–2039. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact